BR9705509A - Deivados de 4-hidroxi-piperidina. - Google Patents

Deivados de 4-hidroxi-piperidina.

Info

Publication number
BR9705509A
BR9705509A BR9705509-3A BR9705509A BR9705509A BR 9705509 A BR9705509 A BR 9705509A BR 9705509 A BR9705509 A BR 9705509A BR 9705509 A BR9705509 A BR 9705509A
Authority
BR
Brazil
Prior art keywords
hydroxy
piperidine derivatives
double bond
hydrogen
independently
Prior art date
Application number
BR9705509-3A
Other languages
English (en)
Other versions
BR9705509B1 (pt
Inventor
Alexander Alanine
Bernd Buettelmann
Marie-Paule Heitz Neidhart
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9705509A publication Critical patent/BR9705509A/pt
Publication of BR9705509B1 publication Critical patent/BR9705509B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE 4-HIDROXI-PIPERIDINA"<D>. A presente invenção refere-se a derivados de 4-hidróxi-piperidina de fórmula geral em que X representa -O-, -NH-, -CH~ 2~, -CHOH-, -CO-, -S-, -SO- OU - SO~ 2~-; R^ 1^ - R^ 4^ são, independentemente um do outro, hidrogênio, hidroxi, sulfonilamino-alquila inferior, 1- ou 2-imidazolila ou acetamido; R^ 5^ - R^ 8^ são, independentemente um do outro, hidrogênio, hidroxi, alquila inferior, alcoxi inferior, trifluorometila ou trifluorometiloxi; a e b podem ser uma ligação dupla, desde que, quando "a" for uma ligação dupla, "b" não poderá ser uma ligação dupla; n é 0 -2; m é 1-3; p é 0 ou 1 e seus sais farmaceuticamente aceitáveis. Os compostos da presente invenção são bloqueadores seletivos do subtipo de receptor de NMDA (N-metil-D-aspartato) que podem ser utilizados na mediação de processos subjacentes do SNC, incluindo o aprendizado e a formação e função da memória.
BRPI9705509-3A 1996-12-03 1997-12-02 derivados de 4-hidràxi-piperidina, processo para a preparaÇço dos mesmos, bem como medicamento contendo os mesmos. BR9705509B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96119345 1996-12-03

Publications (2)

Publication Number Publication Date
BR9705509A true BR9705509A (pt) 2000-03-14
BR9705509B1 BR9705509B1 (pt) 2009-01-13

Family

ID=8223458

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9705509-3A BR9705509B1 (pt) 1996-12-03 1997-12-02 derivados de 4-hidràxi-piperidina, processo para a preparaÇço dos mesmos, bem como medicamento contendo os mesmos.

Country Status (30)

Country Link
US (1) US6359138B1 (pt)
JP (1) JP3045988B2 (pt)
KR (1) KR100257947B1 (pt)
CN (2) CN1162425C (pt)
AR (1) AR009641A1 (pt)
AT (1) ATE205830T1 (pt)
AU (1) AU736597B2 (pt)
BR (1) BR9705509B1 (pt)
CA (1) CA2220649C (pt)
CO (1) CO4910155A1 (pt)
CZ (1) CZ376997A3 (pt)
DE (1) DE69706813T2 (pt)
DK (1) DK0846683T3 (pt)
ES (1) ES2163086T3 (pt)
HK (1) HK1011859A1 (pt)
HR (1) HRP970653B1 (pt)
ID (1) ID17678A (pt)
IL (1) IL122352A0 (pt)
MA (1) MA24410A1 (pt)
NO (1) NO975541L (pt)
NZ (1) NZ329271A (pt)
PE (1) PE20499A1 (pt)
PL (1) PL323447A1 (pt)
PT (1) PT846683E (pt)
RU (1) RU2184112C2 (pt)
SG (1) SG71062A1 (pt)
TR (1) TR199701488A2 (pt)
UY (1) UY24797A1 (pt)
YU (1) YU46997A (pt)
ZA (1) ZA9710653B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
US7005432B2 (en) * 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
HUP0401522A2 (en) * 2004-07-29 2006-04-28 Richter Gedeon Vegyeszet New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
TW200621677A (en) * 2004-09-21 2006-07-01 Astellas Pharma Inc Cyclic amine derivative or salt thereof
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
RU2538982C1 (ru) * 2013-11-19 2015-01-10 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Нижегородский Государственный Университет Им. Н.И. Лобачевского" Производное n-(1s)-1',2',3'-триметокси-6,7-дигидро-1н-бензо[5',6':5,4]циклогепта-[3,2-f]бензофуран-1-ил)ацетамида и его применение
EP3233077A4 (en) * 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE546389C (de) 1927-12-30 1932-03-14 Ralph Mayhew Vorrichtung zur Bedienung von Tasteninstrumenten
US3476760A (en) 1967-03-06 1969-11-04 Smithkline Corp Substituted piperidinoalkylthianaphthenes and benzofurans
US3506671A (en) * 1967-11-01 1970-04-14 Smithkline Corp 1-naphthylalkyl-4-phenylpiperidine derivatives
US3557123A (en) * 1967-11-01 1971-01-19 Smith Kline French Lab 1-naphthylalkyl-4-phenylpiperidine derivatives
DE2507782A1 (de) 1975-02-22 1976-09-02 Merck Patent Gmbh Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung
US4016281A (en) 1975-02-22 1977-04-05 Merck Patent Gesellschaft Mit Beschrankter Haftung Tetralone and indanone compounds
US4039676A (en) 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
GB8515388D0 (en) 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
GB8515389D0 (en) 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
DE69132141T2 (de) 1990-05-10 2000-09-21 Pfizer Inc., New York Neuroprotective indolone und verwandte derivate
DE4140542A1 (de) 1991-12-09 1993-06-17 Bayer Ag Piperdylmethyl substituierte chormanderivate
US5436255A (en) 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors

Also Published As

Publication number Publication date
NO975541D0 (no) 1997-12-02
PE20499A1 (es) 1999-03-05
AU736597B2 (en) 2001-08-02
CN1162425C (zh) 2004-08-18
PT846683E (pt) 2002-02-28
BR9705509B1 (pt) 2009-01-13
UY24797A1 (es) 2000-12-29
PL323447A1 (en) 1998-06-08
ID17678A (id) 1998-01-22
CA2220649A1 (en) 1998-06-03
HRP970653B1 (en) 2001-12-31
JPH10168060A (ja) 1998-06-23
CN1349989A (zh) 2002-05-22
SG71062A1 (en) 2000-03-21
JP3045988B2 (ja) 2000-05-29
KR19980063726A (ko) 1998-10-07
CZ376997A3 (cs) 1998-06-17
ES2163086T3 (es) 2002-01-16
HRP970653A2 (en) 1998-10-31
TR199701488A2 (xx) 1998-06-22
AU4684197A (en) 1998-06-04
CN1086702C (zh) 2002-06-26
IL122352A0 (en) 1998-04-05
DK0846683T3 (da) 2001-11-05
MA24410A1 (fr) 1998-07-01
KR100257947B1 (ko) 2000-07-01
ZA9710653B (en) 1998-06-03
HK1011859A1 (en) 1999-07-23
US6359138B1 (en) 2002-03-19
NZ329271A (en) 1998-12-23
RU2184112C2 (ru) 2002-06-27
ATE205830T1 (de) 2001-10-15
NO975541L (no) 1998-06-04
CA2220649C (en) 2007-02-13
DE69706813D1 (de) 2001-10-25
CO4910155A1 (es) 2000-04-24
AR009641A1 (es) 2000-04-26
DE69706813T2 (de) 2002-04-04
YU46997A (sh) 2000-12-28
CN1188111A (zh) 1998-07-22

Similar Documents

Publication Publication Date Title
BR0011770A (pt) Composto, e, composição farmacêutica
TW347387B (en) Piperidine derivatives
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
AR038430A2 (es) Derivados de parahercuamida b
DK0850221T3 (da) Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister
BR0011863A (pt) Conjugados de fitosterol ou fitostanol com ácido ascórbico e uso destes no tratamento ou prevenção de doença cardiovascular
BR0113629A (pt) Inibidores da adesão celular mediada por alfa4
BR9705509A (pt) Deivados de 4-hidroxi-piperidina.
YU30197A (sh) Derivati 4-hidroksi-piperidina, lekovi koji ih sadrže i postupci za njihovu proizvodnju
BR9811521A (pt) Composição para tratar ou impedir a glomerulopatia
TR199800027T1 (xx) Difenilmetilen piperidin t�revleri.
YU52000A (sh) Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
ATE157080T1 (de) Ethanolaminderivate mit anti-pollakiurawirkung
PE20020144A1 (es) Derivados de pleuromutilinas como agentes antibacterianos
ATE109484T1 (de) Thienopyridin -derivative und diese enthaltende arzneimittel.
BR9916318A (pt) Compostos bicìclicos
BG104069A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
BR9810657A (pt) &#34;processo de preparação de um per-hidroisoindol substituìdo&#34;
BR0312798A (pt) Derivados de isotiazol úteis como agentes anticancerìgenos
MX9604368A (es) Antagonistas de receptores de endotelina.
BR9901058A (pt) N-cail e n-aroil aralquil amidas.
MY135774A (en) Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them.
MD522G2 (ro) Noi derivaţi de piperidinii tioindol, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizare a lor ca analgezice
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/02/2009, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE AS 14A E 15A ANUIDADES.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 14A, 15A, 16A, 17A E 18A ANUIDADES. PAGAR RESTAURACAO.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.